Chiral metal-organic frameworks incorporating nanozymes as neuroinflammation inhibitors for managing Parkinson’s disease
Wei Jiang(Zhengzhou University), Kelong Fan(Institute of Biophysics), Qianyu Lin(Second Affiliated Hospital of Zhengzhou University), Xinyao Zhou(University of Pennsylvania), Qing Li(Second Affiliated Hospital of Zhengzhou University), Jingyun Li(Chinese Academy of Sciences), Xiyun Yan(Zhongyuan University of Technology), Ruofei Zhang(Chinese Academy of Sciences), Jianru Li(Second Affiliated Hospital of Zhejiang University)
Cited by 146
Related Papers
Matching the kinetics of natural enzymes with a single-atom iron nanozyme
|Nature Catalysis|2021|1.1k
Nanozymes: A clear definition with fuzzy edges
|Nano Today|2021|559
Superoxide dismutase nanozymes: an emerging star for anti-oxidation
|Journal of Materials Chemistry B|2021|483
Nanozyme for tumor therapy: Surface modification matters
|Exploration|2021|425
Commercial proteases: Present and future
|FEBS Letters|2013|238